Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma A total of 501 patients were included in the analysis: 287 received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results